Search
Ivarmacitinib
go.drugbank.com/drugs/DB16756InvestigationalWhile ivarmactinib has yet to receive marketing authorization, as of February 2022 clinical trials are ongoing or completed evaluating its use in atopic dermatitis,[L40604,L40619,L40629] ankylosing spondylitis
Anthramycin
go.drugbank.com/drugs/DB19555ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Anthramycin is a antibiotic, produced by Streptomyces strain. Anthramycin has a monoisotopic molecular weight of 315.12 Da.
Rutamycin
go.drugbank.com/drugs/DB19908ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Rutamycin is a antibiotic, produced by Streptomyces strain. Rutamycin has a monoisotopic molecular weight of 776.51 Da.
Heliomycin
go.drugbank.com/drugs/DB20233ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Heliomycin is a antibiotic, produced by Streptomyces strain. Heliomycin has a monoisotopic molecular weight of 376.09 Da.
Neutramycin
go.drugbank.com/drugs/DB20809ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Neutramycin is a antibiotic, produced by Streptomyces strain. Neutramycin has a monoisotopic molecular weight of 686.35 Da.
Nogalamycin
go.drugbank.com/drugs/DB20882ExperimentalThe usage of the INN stem '-mycin' in the name indicates that Nogalamycin is a antibiotic, produced by Streptomyces strain. Nogalamycin has a monoisotopic molecular weight of 787.31 Da.
Eltenac
go.drugbank.com/drugs/DB20457ExperimentalEltenac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Eltenac is a anti-inflammatory agent, ibufenac derivative. Eltenac has a monoisotopic molecular weight of 300.97 Da.
Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalMyrcludex B
go.drugbank.com/drugs/DB14853InvestigationalWith Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D). … Myrcludex B is under investigation in clinical trial NCT03546621 (A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination
Fontolizumab
go.drugbank.com/drugs/DB05111InvestigationalFontolizumab (marketed under the trade name HuZAF™) is a humanized monoclonal antibody which is used as an immunosuppressive drug to treat Crohn's disease.